peoplePerson
Eileen M. O'Reilly
Leading pancreatic cancer trialist, including the maintenance PARP-inhibitor and germline-BRCA studies.
Directs pancreatic and hepatobiliary cancer research at MSK; a leader of trials in BRCA-mutant pancreatic cancer and of NCI cooperative group GI studies.
Role
Winthrop Rockefeller Chair in Medical Oncology; Section Head, Hepatopancreaticobiliary and Neuroendocrine Cancers
Institution
Specialisms
Pancreatic cancerBiliary cancerBRCA-associated pancreatic cancer
Profiles
| Title | Journal | Year |
|---|---|---|
| Randomized, multicenter, phase II trial of gemcitabine and cisplatin with or without veliparib in patients with pancreas adenocarcinoma and a germline BRCA/PALB2 mutation | Journal of Clinical Oncology | 2020 |